Extending ID Access Through Technology Enabled, Predictive Care
We believe the best way to revolutionize infectious disease treatment starts with leveraging technology to leapfrog legacy approaches. Our tech stack is at the core of our innovative programs.
Step 1 - World Class Network of ID Physicians
Provider Network
Organize independent ID physicians into an ID network to support care delivery with VBC contracts
Practice Tech Stack
Optimize FFS operations by using a single practice tech stack
Step 2 - World's Largest Data Registry of ID Patients
Data Warehouse
Obtain patient records from providers and partner facilities
Providers & Facilities
Facilities providing clinical data enroll in ID Stewardship programs to reduce ID-related costs
Step 3 - Shared Insights From Data Analytics for Providers
Reduced Variability
Iterate and improve care delivery consistency through best practices and technology improvements
ID Center of Excellence
Expand national virtual care delivery around best practices from an ID Center of Excellence
Step 4 - Shared Data With Life Science
Real-World Evidence
Real-time data with ample population sample size and diversity
Accelerated Research
Data insights are pooled for life sciences companies to commercialize new treatments
Step 5 - Clinical Trials
Site Management
Find and coordinate best provider location for research and trials
Patient Enrollment
Patients from our ID network invited to enroll
Step 6 - Value Based Care Arrangements
Key Learnings
Prepare physicians for value-based care models based on key learnings from ID Center of Excellence
Shared Savings
Shared savings, such as reducing readmissions leading to risk-bearing arrangements
Step 7 - ID Navigator SaaS app
Predictive Tools (AI)
Utilize data and insights for proactive ID management and prevention
ID Extender
SaaS app for healthcare when an ID doc is not available
Stakeholder Benefits
Our approach brings together the brightest minds to innovate solutions using data, and then make those solutions available to the global market via our platform to enable better care delivery through technology. The platform will be made available to medical practices, physicians, healthcare facilities, patient care provider organizations, life sciences companies, payors and patients.
A few of the “Big Impacts” include:
Improved Access
Support Clinical Research
Enhanced Outcomes
Reduced Costs
![](https://i.postimg.cc/Vk6LVHd5/bigimage1.webp)
![](https://i.postimg.cc/Vk6LVHd5/bigimage1.webp)
Payor Solutions
In 2022, the Infectious Diseases Society of America (IDSA) drafted a Value-Based Care enablement strategy for infectious diseases.
The IDSA strategy has not yet been implemented, in part, because VBC-enablement requires an ID provider network - which doesn't yet exist. Until now.
Transitioning ID providers into VBC arrangements could generate billions of dollars of pooled ID healthcare savings.
We aim to be the first VBC-enablement champion for infectious diseases.